Tag: Mayne Pharma
Mayne Pharma sells US retail generics portfolio for $134 million
Australian pharmaceutical manufacturing company Mayne Pharma has completed the sale of its US retail generics portfolio to Dr. Reddy’s Laboratories for approximately $134 million.Â
Mayne Pharma opens new manufacturing facility in the US
Australian-listed pharmaceutical company Mayne Pharma has officially opened its new oral solid-dose commercial manufacturing facility in Greenville, North Carolina, USA.
According to the company media statement, the $80...
Mayne Pharma to acquire a portfolio of US generic products from Teva and Allergen
ASX-listed specialty pharmaceutical company Mayne Pharma has entered into a binding agreement to acquire a portfolio of US generic products from Teva and Allergen for...
Featured Article
The future of steel engineering: Using CRM systems across supply chains
The construction industry has undergone significant transformation over the past twenty years. Speedpanel, a leading Australian manufacturer of lightweight, fire-rated, and acoustic wall systems, made a groundbreaking entrance in the early '90s, revolutionising the Australian construction landscape.
